What is the UK CTR and what are its goals? 

The UK Clinical Trials Regulation (UK CTR) was signed into law on 11 April 2025, with a 12-month rollout now underway. It has been described by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) as the “biggest regulatory shake-up of clinical trials in 20 years.”  The regulation sets out ambitious goals: to strengthen patient safety, speed up approvals, […]

Reviving Clinical Research: The UK CTR and a New Era for Innovation

The UK’s Clinical Trials Regulation (CTR), signed into law in April 2025, aims to foster innovation, accelerate approvals, and enable patient participation in research while safeguarding their safety and rights. Supporting innovation is a key priority for the Medicines and Healthcare products Regulatory Agency (MHRA), particularly as the UK has experienced a steady decline in […]